These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 29186616
21. Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-beta1-stimulated collagenase-3 expression in human breast cancer cells. Selvamurugan N, Kwok S, Partridge NC. J Biol Chem; 2004 Jun 25; 279(26):27764-73. PubMed ID: 15084595 [Abstract] [Full Text] [Related]
22. Epigenetic regulation of Smad2 and Smad3 by profilin-2 promotes lung cancer growth and metastasis. Tang YN, Ding WQ, Guo XJ, Yuan XW, Wang DM, Song JG. Nat Commun; 2015 Sep 10; 6():8230. PubMed ID: 26354229 [Abstract] [Full Text] [Related]
23. A novel mechanism of TGFbeta-induced actin reorganization mediated by Smad proteins and Rho GTPases. Vardouli L, Vasilaki E, Papadimitriou E, Kardassis D, Stournaras C. FEBS J; 2008 Aug 10; 275(16):4074-87. PubMed ID: 18631173 [Abstract] [Full Text] [Related]
24. A positive role for Myc in TGFbeta-induced Snail transcription and epithelial-to-mesenchymal transition. Smith AP, Verrecchia A, Fagà G, Doni M, Perna D, Martinato F, Guccione E, Amati B. Oncogene; 2009 Jan 22; 28(3):422-30. PubMed ID: 18978814 [Abstract] [Full Text] [Related]
31. SND1 acts as a novel gene transcription activator recognizing the conserved Motif domains of Smad promoters, inducing TGFβ1 response and breast cancer metastasis. Yu L, Di Y, Xin L, Ren Y, Liu X, Sun X, Zhang W, Yao Z, Yang J. Oncogene; 2017 Jul 06; 36(27):3903-3914. PubMed ID: 28263968 [Abstract] [Full Text] [Related]
36. Activation of Wnt/β-catenin signalling is required for TGF-β/Smad2/3 signalling during myofibroblast proliferation. Xu L, Cui WH, Zhou WC, Li DL, Li LC, Zhao P, Mo XT, Zhang Z, Gao J. J Cell Mol Med; 2017 Aug 06; 21(8):1545-1554. PubMed ID: 28244647 [Abstract] [Full Text] [Related]
37. Inner nuclear membrane protein TMEM201 promotes breast cancer metastasis by positive regulating TGFβ signaling. Kong Y, Zhang Y, Wang H, Kan W, Guo H, Liu Y, Zang Y, Li J. Oncogene; 2022 Jan 06; 41(5):647-656. PubMed ID: 34799661 [Abstract] [Full Text] [Related]
38. Smad signaling is required to maintain epigenetic silencing during breast cancer progression. Papageorgis P, Lambert AW, Ozturk S, Gao F, Pan H, Manne U, Alekseyev YO, Thiagalingam A, Abdolmaleky HM, Lenburg M, Thiagalingam S. Cancer Res; 2010 Feb 01; 70(3):968-78. PubMed ID: 20086175 [Abstract] [Full Text] [Related]
39. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression. Ali A, Zhang P, Liangfang Y, Wenshe S, Wang H, Lin X, Dai Y, Feng XH, Moses R, Wang D, Li X, Xiao J. Cell Death Dis; 2015 Mar 12; 6(3):e1681. PubMed ID: 25766320 [Abstract] [Full Text] [Related]
40. Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity. Rypens C, Marsan M, Van Berckelaer C, Billiet C, Melis K, Lopez SP, van Dam P, Devi GR, Finetti P, Ueno NT, Bertucci F, Dirix P, Neven P, Vermeulen P, Dirix L, Van Laere SJ. Breast Cancer Res Treat; 2020 Apr 12; 180(2):385-395. PubMed ID: 32043194 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]